We are dedicated to serving the animal health community

Med-Pharmex has been working hard over the past year to improve our processes & services. We are a fully integrated formulation and regulatory product development company providing affordable, quality generics to support the health of animals.

Our Mission

For over 35 years, we’ve committed to serving the animal health community by providing products to extend the health span of companion animals and ensure a safe and abundant food supply. We believe every animal deserves proper care, that’s why we aim to create accessible and results-driven, quality products. 

Our History

Founding

Med-Pharmex, Inc was founded in San Dimas, CA by Gerald Macedo

Derma-Vet®

Derma-Vet® was added to our portfolio with an Ointment NADA

Relocation to Current Site​

Med-Pharmex relocated to the Pomona, CA location

Vet Betagen®

Vet Betagen® was added to our portfolio with an ANADA

Betagen®​ Miconazole

Betagen®​ was added to our portfolio with an ANADA

Four Products Added

Tetrasol®​, Neosol®​, Sulfasol®​, and Sulforal® ​ were added to our product offering with ANADAs

Cephazone Pharma, LLC Established

Cephazone was established as a production branch

Euthanasia III®

Euthanasia III Solution ANADA was added

Ivermectin Paste

Added Ivermectin 1.87% ANADA

DW Healthcare Partners

DW Healthcare Partners acquires 50% equity of Med-Pharmex

Florcon® & Mometavet®

Florcon® Solution & Mometavet® Otic ANADA’s were approved

Expansion to 2755

Med-Pharmex added additional building to Pomona campus

2020 New Leadership

Paul Hays joins the team as the new CEO
1983
1989
1995
2000
2005-2006
2012
2016
2017
2020

Letter from the CEO

“We’re committed to serving our partners & the animals they care for”

As we look ahead, we will continue to innovate and reliably deliver quality products that meet our customers’ needs.

Paul Hays

President & Chief Executive Officer

Michael Park

Chief Financial Officer

Edward Adrian

VP Operations

Gautam Shah

VP Quality, Regulatory & Compliance

Our Values

These Values Reflect Who We Are

Med-Pharmex has an over 35-year legacy of rapidly developing and efficiently supplying generic animal health products to its customers.

We listen to our customer’s feedback and stay in-tune to market trends. Over the years, we have cultivated numerous private label partnerships with leading distributors. Have feedback? Send us a message.

At Med-Pharmex, we prioritize a culture of continuous quality improvement. Our processes and facilities follow Current Good Manufacturing Practice regulations enforced by the FDA.

We strive to provide affordable, quality generics to support the health of animals, products that are trusted and appreciated by their caregivers.

Our Careers

When we connect like-minded individuals towards a unified goal, great things can be accomplished. We want to work with individuals with a passion for providing quality care to all animals. Together everyone achieves more.

Gautam Shah

VP Quality, Regulatory & Compliance

>30 years experience as quality professional in the pharmaceutical industry

Zydus Cadila (Nesher Pharmaceuticals ~3 yrs as VP, Quality), Dow Corning (~5 yrsas Global Quality Head), Sun Pharmaceuticals, Ltd (Caraco Pharmaceutical >10 yrs as QA Lead), Cipla, Nicholas Piramal 

Edward Adrian

>25 years experience in manufacturing, engineering, quality

Tolmar Pharmaceuticals (19 yrs-7 as VP, Operations), Schering-Plough Animal Health 

Michael Park

>30 years experience in Public and Corporate Accounting and Finance

Anchen Pharmaceuticals (5 years as SVP Finance), Photon Dynamics, Proxim Corporation

Paul Hays

>35 years experience in animal health

Chief executive roles: Virbac Corporation (North America), Synbiotics/Pfizer (Global), Boehringer Ingelheim (USA)

3 turnarounds, including driving extensive cGMP remediation activities at Virbac Corporation’s Bridgeton, MO facility resulting in a successful Warning Letter close-out

This website uses cookies to ensure you get the best experience on our website.

Companion

Equine

Livestock